In vitro activity of five new quinolones against cultivable mycobacteria.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000031:analogs & derivatives / Q000494:pharmacology*; D024841:Fluoroquinolones; D008826:Microbial Sensitivity Tests; D009161:Mycobacterium / Q000187:drug effects*; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D009643:Norfloxacin / Q000031:analogs & derivatives / Q000494:pharmacology*; D015242:Ofloxacin; D010078:Oxazines / Q000494:pharmacology*; D015366:Pefloxacin
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D010078:Oxazines; D015366:Pefloxacin; D002939:Ciprofloxacin; C040691:amifloxacin; D015242:Ofloxacin; D009643:Norfloxacin